238 related articles for article (PubMed ID: 28054552)
1. c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis.
Zhang J; Wang S; Jiang B; Huang L; Ji Z; Li X; Zhou H; Han A; Chen A; Wu Y; Ma H; Zhao W; Zhao Q; Xie C; Sun X; Zhou Y; Huang H; Suleman M; Lin F; Zhou L; Tian F; Jin M; Cai Y; Zhang N; Li Q
Nat Commun; 2017 Jan; 8():13732. PubMed ID: 28054552
[TBL] [Abstract][Full Text] [Related]
2. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation.
Li H; Lu S; Chen Y; Zheng L; Chen L; Ding H; Ding J; Lou D; Liu F; Zheng B
Cell Signal; 2019 Jun; 58():99-110. PubMed ID: 30877036
[TBL] [Abstract][Full Text] [Related]
3. c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3.
Ma H; Zhang J; Zhou L; Wen S; Tang HY; Jiang B; Zhang F; Suleman M; Sun D; Chen A; Zhao W; Lin F; Tsau MT; Shih LM; Xie C; Li X; Lin D; Hung LM; Cheng ML; Li Q
Cell Rep; 2020 Mar; 30(12):4235-4249.e6. PubMed ID: 32209481
[TBL] [Abstract][Full Text] [Related]
4. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
5. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
6. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.
Kang M; Lee SM; Kim W; Lee KH; Kim DY
Biochem Biophys Res Commun; 2019 Apr; 512(1):93-99. PubMed ID: 30871777
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
8. ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.
Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
[TBL] [Abstract][Full Text] [Related]
9. A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis.
Blaha CS; Ramakrishnan G; Jeon SM; Nogueira V; Rho H; Kang S; Bhaskar P; Terry AR; Aissa AF; Frolov MV; Patra KC; Brooks Robey R; Hay N
Nat Commun; 2022 Feb; 13(1):899. PubMed ID: 35173161
[TBL] [Abstract][Full Text] [Related]
10. Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans.
Wang H; Liu B; Al-Aidaroos AQ; Shi H; Li L; Guo K; Li J; Tan BC; Loo JM; Tang JP; Thura M; Zeng Q
Oncogene; 2016 Jun; 35(25):3303-13. PubMed ID: 26455318
[TBL] [Abstract][Full Text] [Related]
11. A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer.
Ma Y; Yu C; Mohamed EM; Shao H; Wang L; Sundaresan G; Zweit J; Idowu M; Fang X
Oncogene; 2016 Nov; 35(47):6132-6142. PubMed ID: 27132509
[TBL] [Abstract][Full Text] [Related]
12. SILAC Quantitative Proteomics and Biochemical Analyses Reveal a Novel Molecular Mechanism by Which ADAM12S Promotes the Proliferation, Migration, and Invasion of Small Cell Lung Cancer Cells through Upregulating Hexokinase 1.
Duan Q; Li D; Xiong L; Chang Z; Xu G
J Proteome Res; 2019 Jul; 18(7):2903-2914. PubMed ID: 31117637
[TBL] [Abstract][Full Text] [Related]
13. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
[TBL] [Abstract][Full Text] [Related]
14. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
15. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
16. c-Src facilitates tumorigenesis by phosphorylating and activating G6PD.
Ma H; Zhang F; Zhou L; Cao T; Sun D; Wen S; Zhu J; Xiong Z; Tsau MT; Cheng ML; Hung LM; Zhou Y; Li Q
Oncogene; 2021 Apr; 40(14):2567-2580. PubMed ID: 33686238
[TBL] [Abstract][Full Text] [Related]
17. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition.
Tseng PL; Chen CW; Hu KH; Cheng HC; Lin YH; Tsai WH; Cheng TJ; Wu WH; Yeh CW; Lin CC; Tsai HJ; Chang HC; Chuang JH; Shan YS; Chang WT
Oncotarget; 2018 Apr; 9(27):18949-18969. PubMed ID: 29721175
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
19. N
Wang Q; Guo X; Li L; Gao Z; Su X; Ji M; Liu J
Cell Death Dis; 2020 Oct; 11(10):911. PubMed ID: 33099572
[TBL] [Abstract][Full Text] [Related]
20. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]